Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes

医学 急性肾损伤 内科学 腹水 肌酐 肝硬化 肝肾综合征 胃肠病学 肾脏疾病 肝病学 终末期肝病模型 肝移植 移植
作者
Florence Wong,Jacqueline G. O’Leary,K. Rajender Reddy,Guadalupe García‐Tsao,Michael B. Fallon,Scott W. Biggins,Ram Subramanian,Paul J. Thuluvath,Patrick S. Kamath,Heather Patton,Benedict Maliakkal,Puneeta Tandon,Hugo E. Vargas,Leroy R. Thacker,J.S. Bajaj
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:112 (7): 1103-1110 被引量:75
标识
DOI:10.1038/ajg.2017.122
摘要

The International Ascites Club (IAC) recently defined Stage 1 acute kidney injury (AKI) for cirrhosis as an acute increase in serum creatinine (SCr) by ≥0.3 mg/dl or by ≥50% in <48 h from a stable value within 3 months. The baseline SCr may influence AKI risk and patient outcomes. The objective of this study is to determine in cirrhosis whether the baseline SCr has any effect on the in-hospital AKI course and patient survival.North American Consortium for the Study of End-Stage Liver Disease is a consortium of tertiary-care hepatology centers prospectively enroling non-elective cirrhotic inpatients. Patients with different baseline SCr levels (≤0.5, 0.51-1.0, 1.01-1.5, >1.5 mg/dl) were evaluated for the development of AKI, and compared for AKI outcomes and 30-day survival.653 hospitalized cirrhotics (56.7±10years, 64% men, 30% with infection) were included. The incidence of AKI was 47% of enrolled patients. Patients with higher baseline SCr were more likely to develop AKI, with significantly higher delta and peak SCr (P<0.001) than the other groups, more likely to have a progressive AKI course (P<0.0001), associated with a significantly reduced 30-day survival (P<0.0001). Multivariate logistic regression showed that the delta SCr during an AKI episode to be the strongest factor impacting AKI outcomes and survival (P<0.001), with a delta SCr of 0.70 mg/dl having a 68% sensitivity and 80% specificity for predicting 30-day mortality.Admitted cirrhotic patients with higher baseline SCr are at higher risk for in-hospital development of AKI, and more likely to have AKI progression with reduced survival. Therefore, such patients should be closely monitored and treated promptly for their AKI.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
xing_xing的应助被科研通管家采纳,获得20
1秒前
深情安青的应助被科研通管家采纳,获得10
1秒前
渡人舟的应助被科研通管家采纳,获得10
1秒前
yzy发布了新的文献求助10
1秒前
Maestro_S的应助被科研通管家采纳,获得10
1秒前
SciGPT的应助被科研通管家采纳,获得10
2秒前
科目三的应助被科研通管家采纳,获得10
2秒前
天天快乐的应助被科研通管家采纳,获得30
2秒前
nini完成签到,获得积分10
2秒前
乐空思的应助被贪玩的幻姬采纳,获得20
2秒前
归远完成签到,获得积分10
2秒前
慕青的应助被科研通管家采纳,获得10
2秒前
淡然丹妗完成签到,获得积分10
2秒前
2秒前
搜集达人的应助被科研通管家采纳,获得10
2秒前
梁羽生完成签到,获得积分10
2秒前
Ssssssinan的应助被科研通管家采纳,获得10
2秒前
zhouzhou完成签到 ,获得积分10
2秒前
王鹏飞的应助被科研通管家采纳,获得10
2秒前
xing_xing的应助被科研通管家采纳,获得20
2秒前
NexusExplorer的应助被科研通管家采纳,获得10
3秒前
33发布了新的文献求助10
3秒前
JamesPei的应助被科研通管家采纳,获得10
3秒前
SciGPT的应助被科研通管家采纳,获得10
3秒前
wwsss完成签到,获得积分10
3秒前
CodeCraft的应助被科研通管家采纳,获得10
3秒前
3秒前
上官若男的应助被科研通管家采纳,获得10
3秒前
3秒前
星星完成签到,获得积分10
3秒前
Hello的应助被科研通管家采纳,获得10
3秒前
Akim的应助被科研通管家采纳,获得10
3秒前
xiaohui发布了新的文献求助30
4秒前
王鹏飞的应助被科研通管家采纳,获得10
4秒前
斯文败类的应助被科研通管家采纳,获得10
4秒前
4秒前
秋风的应助被科研通管家采纳,获得10
4秒前
共享精神的应助被科研通管家采纳,获得10
4秒前
FashionBoy的应助被科研通管家采纳,获得10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185762
求助须知:如何正确求助?哪些是违规求助? 9574458
关于积分的说明 21836217
捐赠科研通 7783574
什么是DOI,文献DOI怎么找? 3434651
关于科研通互助平台的介绍 2559017
邀请新用户注册赠送积分活动 2481466